Back to Search
Start Over
Effective inhibition of coronavirus replication by Polygonum cuspidatum .
- Source :
-
Frontiers in bioscience (Landmark edition) [Front Biosci (Landmark Ed)] 2021 Oct 30; Vol. 26 (10), pp. 789-798. - Publication Year :
- 2021
-
Abstract
- Background : The coronavirus disease 2019 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has infected more than 210 million individuals globally and resulted in over 4 million deaths since the first report in December 2019. The early use of traditional Chinese medicine (TCM) for light and ordinary patients, can rapidly improve symptoms, shorten hospitalization days and reduce severe cases transformed from light and normal. Many TCM formulas and products have a wide application in treating infectious and non-infectious diseases. Polygonum cuspidatum Sieb. et Zucc. ( P. cuspidatum ), is an important Traditional Chinese Medicine with actions of clearing away heat and eliminating dampness, draining the gallbladder to relieve jaundice, removing blood stasis to alleviate pain, resolving phlegm and arrest cough. In the search for anti-SARS-CoV-2, P. cuspidatum was recommended as as a therapeutic drug of COVID-19 pneumonia.In this study, we aimed to identifies P. cuspidatum is the potential broad-spectrum inhibitor for the treatment of coronaviruses infections. Methods : In the present study , we infected human malignant embryonal rhabdomyoma (RD) cells with the OC43 strain of the coronavirus, which represent an alternative model for SARS-CoV-2 and then employed the cell viability assay kit for the antiviral activity. We combined computer aided virtual screening to predicte the binding site and employed Surface plasmon resonance analysis (SPR) to comfirm the interaction between drugs and coronavirus. We employed fluorescence resonance energy transfer technology to identify drug's inhibition in the proteolytic activity of 3CLpro and Plpro. Results : Based on our results, polydatin and resveratrol derived from P. cuspidatum significantly suppressed HCoV-OC43 replication. 50% inhibitory concentration (IC <subscript>50</subscript> ) values of polydatin inhibited SARS-CoV-2 Mpro and Plpro, MERS Mpro and Plpro were 18.66, 125, 14.6 and 25.42 μm, respectively. IC <subscript>50</subscript> values of resveratrol inhibited SARS-CoV-2 Mpro and Plpro, MERS Mpro and Plpro were 29.81 ,60.86, 16.35 and19.04 μM, respectively. Finally, SPR assay confirmed that polydatin and resveratrol had high affinity to SARS-CoV-2, SARS-CoV 3Clpro, MERS-CoV 3Clpro and PLpro protein. Conclusions : we identified the antiviral activity of flavonoids polydatin and resveratrol on RD cells. Polydatin and resveratrol were found to be specific and selective inhibitors for SARS-CoV-2, 3CLpro and PLpro, viral cysteine proteases. In summary, this study identifies P. cuspidatum as the potential broad-spectrum inhibitor for the treatment of coronaviruses infections.<br /> (© 2021 The Author(s). Published by BRI.)
- Subjects :
- Antiviral Agents pharmacology
COVID-19 epidemiology
COVID-19 prevention & control
COVID-19 virology
Cell Line, Tumor
Cell Survival drug effects
Glucosides metabolism
HEK293 Cells
Host-Pathogen Interactions drug effects
Humans
Medicine, Chinese Traditional methods
Pandemics
Protein Binding
Resveratrol metabolism
SARS-CoV-2 metabolism
SARS-CoV-2 physiology
Stilbenes metabolism
Surface Plasmon Resonance methods
Viral Proteins metabolism
Drugs, Chinese Herbal chemistry
Fallopia japonica chemistry
Glucosides pharmacology
Resveratrol pharmacology
SARS-CoV-2 drug effects
Stilbenes pharmacology
Virus Replication drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 2768-6698
- Volume :
- 26
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Frontiers in bioscience (Landmark edition)
- Publication Type :
- Academic Journal
- Accession number :
- 34719206
- Full Text :
- https://doi.org/10.52586/4988